12:00 AM
 | 
Aug 13, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

SUN 13834: Development discontinued

Daiichi disclosed in its earnings for 1Q12 ending June 30 that it discontinued development of SUN 13834, which was...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >